Why Eli Lilly Stock Climbed Today
Demand for the healthcare leader's weight-loss drugs continues to rise.
Overview
Shares of Eli Lilly (NYSE: LLY) rose on Wednesday after the medicine maker highlighted the booming sales of its popular obesity treatments.
Image source: Getty Images.
Eli Lilly's second-quarter revenue surged 48% year over year to $23 billion. The gains were broad-based, with U.S. sales up 33% to $14.4 billion and international revenue up 80% to $8.6 billion.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.